Other news to note
Daewoong Pharmaceutical Co. Ltd., of Seoul, South Korea, and Bioalliance Pharma SA, of Paris, inked a supply and license deal for Sitavig (acyclovir Lauriad) for commercialization rights in South Korea. Daewoong also will take over registering the drug, for use in recurrent labial herpes, in that region. Bioalliance is eligible for up-front and milestone payments, and the deal also includes a double-digit royalty rate. Specific financial terms were not disclosed.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter